Charles S. Berkman, VP, General Counsel & Secretary at LIGAND PHARMACEUTICALS INC (LGND), sold 14,881 shares at $74.50 ($1.1M) on 2014-02-12, disclosed to the SEC on 2014-02-14.
Seasonal sale ($1.1M) by VP, General Counsel & Secretary — this insider has traded LGND in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.50 | 386 | $29K | 2.6% |
| 2 | $74.50 | 1,000 | $75K | 6.7% |
| 3 | $74.50 | 1,166 | $87K | 7.8% |
| 4 | $74.50 | 1,230 | $92K | 8.3% |
| 5 | $74.50 | 1,736 | $129K | 11.7% |
| 6 | $74.50 | 4,584 |
| $342K |
| 30.8% |
| 7 | $74.50 | 4,779 | $356K | 32.1% |
| Total | $74.50 avg | 14,881 | $1.1M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $12K | — | Filing → |
| OABI | SELL | 2025-12-09 | $16K | — | Filing → |
| OABI | SELL | 2025-04-07 | $14K | — | Filing → |